Fibroblast-like synoviocytes in rheumatoid arthritis: Surface markers and phenotypes

被引:196
作者
Wu, Zewen [1 ]
Ma, Dan [2 ]
Yang, Helin [3 ]
Gao, Jinfang [2 ]
Zhang, Gailian [2 ]
Xu, Ke [2 ]
Zhang, Liyun [2 ]
机构
[1] Shanxi Med Univ, Bethune Hosp, Taiyuan, Peoples R China
[2] Shanxi Bethune Hosp, Shanxi Acad Med Sci, Dept Rheumatol, Taiyuan, Peoples R China
[3] Shanxi Univ Chinese Med, Taiyuan, Peoples R China
基金
中国国家自然科学基金;
关键词
Fibroblast-like synoviocyte; Rheumatoid arthritis; Surface marker; ACTIVATION PROTEIN-ALPHA; PREDICTS AGGRESSIVE-BEHAVIOR; PODOPLANIN EXPRESSION; SYNOVIAL FIBROBLASTS; STEM-CELLS; REMODELING INTERFACE; SERINE-PROTEASE; STROMAL CELLS; GROWTH-FACTOR; TUMOR-GROWTH;
D O I
10.1016/j.intimp.2021.107392
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease that mainly affects synovial joints. During the course of RA, the synovium transforms into hyperplastic invasive tissue, leading to cartilage and bone destruction. Fibroblast-like synoviocytes (FLS) in the synovial lining develop aggressive phenotypes and produce pathogenic mediators that lead to the occurrence and progression of disease, playing a major role in RA pathophysiology. Therefore, research on FLS has become the main focus within the RA field. With technical advances and the development of multi-omics comprehensive analysis approaches, it has become possible to identify different FLS subsets via high-throughput sequencing and investigate differences between FLS phenotypes, allowing for the detailed study of RA pathogenesis. This review summarizes recent works on FLS subtypes and the surface marker proteins identified for different subtypes, providing a theoretical basis and reference for future studies on FLS in RA. The current work also addresses the clinical potential of FLS surface markers in RA based on related research from other fields.
引用
收藏
页数:8
相关论文
共 76 条
[1]
Fibroblast activation protein:: a serine protease expressed at the remodeling interface in idiopathic pulmonary flbrosis [J].
Acharya, PS ;
Zukas, A ;
Chandan, V ;
Katzenstein, ALA ;
Puré, E .
HUMAN PATHOLOGY, 2006, 37 (03) :352-360
[2]
[Anonymous], INHIBITION FIBROBLAS
[3]
Tumoral Immune Suppression by Macrophages Expressing Fibroblast Activation Protein-α and Heme Oxygenase-1 [J].
Arnold, James N. ;
Magiera, Lukasz ;
Kraman, Matthew ;
Fearon, Douglas T. .
CANCER IMMUNOLOGY RESEARCH, 2014, 2 (02) :121-126
[4]
Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization [J].
Bagley, Rebecca G. ;
Honma, Nakayuki ;
Weber, William ;
Boutin, Paula ;
Rouleau, Cecile ;
Shankara, Srinivas ;
Kataoka, Shiro ;
Ishida, Isao ;
Roberts, Bruce L. ;
Teicher, Beverly A. .
MICROVASCULAR RESEARCH, 2008, 76 (03) :180-188
[5]
ELECTRON MICROSCOPY OF HUMAN SYNOVIAL MEMBRANE [J].
BARLAND, P ;
NOVIKOFF, AB ;
HAMERMAN, D .
JOURNAL OF CELL BIOLOGY, 1962, 14 (02) :207-+
[6]
Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis [J].
Bartok, Beatrix ;
Firestein, Gary S. .
IMMUNOLOGICAL REVIEWS, 2010, 233 :233-255
[7]
Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes [J].
Bauer, Stefan ;
Jendro, Michael C. ;
Wadle, Andreas ;
Kleber, Sascha ;
Stenner, Frank ;
Dinser, Robert ;
Reich, Anja ;
Faccin, Erica ;
Goedde, Stefan ;
Dinges, Harald ;
Mueller-Ladner, Ulf ;
Renner, Christoph .
ARTHRITIS RESEARCH & THERAPY, 2006, 8 (06)
[8]
Isolation of CD248-expressing stromal vascular fraction for targeted improvement of wound healing [J].
Brett, Elizabeth ;
Zielins, Elizabeth R. ;
Chin, Monica ;
Januszyk, Michael ;
Blackshear, Charles P. ;
Findlay, Michael ;
Momeni, Arash ;
Gurtner, Geoffrey C. ;
Longaker, Michael T. ;
Wan, Derrick C. .
WOUND REPAIR AND REGENERATION, 2017, 25 (03) :414-422
[9]
Brodbeck WG, 1996, J IMMUNOL, V156, P2528
[10]
Circulating CD26 is negatively associated with inflammation in human and experimental arthritis [J].
Busso, N ;
Wagtmann, N ;
Herling, C ;
Chobaz-Péclat, V ;
Bischof-Delaloye, A ;
So, A ;
Grouzmann, E .
AMERICAN JOURNAL OF PATHOLOGY, 2005, 166 (02) :433-442